Table 4.
Percent frequency
|
|||
---|---|---|---|
Neonatal treatment (μg/pup/day) | Total incidencea | Squamous | Adenosquamous |
E2 (5) | 16/37b | 41 (15/37) | 8 (3/37) |
OH-PCB-30 (200) | 10/22b | 36 (8/22) | 14 (3/22) |
OH-PCB-61 (400) | 5/24 | 13 (3/24) | 8 (2/24) |
E2 (2.5)/OH-PCB-30 (100) | 9/19 | 16 (3/19) | 32 (6/19)* |
OH-PCB-30/61 (100 + 100)c | 8/21 | 14 (3/21) | 24 (5/21) |
Pups were treated as described in “Materials and Methods.”
Total incidence is the number of CV tract tumors per total number of mice treated.
Some mice had more than one type of CV tract tumor.
Equal concentrations of OH-PCB-30 and OH-PCB-61 were used as a mixture.
*p < 0.05 versus a combination of E2 (5) and OH-PCB-30 (200), Fisher exact test.